https://bioutah.org/sintx-technologies-announces-receipt-of-more-than-3-2-million-in-contract-manufacturing-purchase-orders/2026-06-25T20:11:45ZBioUtahenSINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders2026-06-25T20:11:45ZBloghttps://bioutah.org/sera-applauds-illinois-initiative-to-expand-medicaid-coverage-for-proteomic-blood-testing-in-pregnancy/2026-06-25T20:02:48ZBioUtahenSERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY2026-06-25T20:02:48ZBloghttps://bioutah.org/myriad-genetics-expands-minimal-residual-disease-testing-for-three-cancer-types/2026-06-25T20:12:39ZBioUtahenMyriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types2026-06-25T19:59:22ZBloghttps://bioutah.org/canary-speech-brings-canary-ambient-to-the-zoom-app-marketplace-putting-real-time-vocal-biomarker-insights-into-every-telehealth-visit/2026-06-25T19:56:55ZBioUtahenCanary Speech Brings Canary Ambient™ to the Zoom App Marketplace, Putting Real-Time Vocal Biomarker Insights Into Every Telehealth Visit2026-06-25T19:55:25ZBlog